Pharmafile Logo
Pharmafocus logo
Advanced Search

Array Biopharma

Showing 5 posts of 5 posts found.

Array Biopharma’s Braftovi triple therapy meets both endpoints in advanced colorectal cancer subtype

May 22, 2019
Research and Development Array Biopharma, Braftovi, Cancer, colorectal cancer, pharma

Array Biopharma has revealed new data on its combination of Braftovi (encorafenib), Mektovi (binimetinib), and Erbitux (cetuximab), showing that it …

News
array_biopharma

Array’s melanoma therapy blasts Roche’s out of water

February 7, 2018
Research and Development Array Biopharma, Pierre Fabre, Roche, biotech, drugs, melanoma, pharma, pharmaceutical

Array Biopharma suffered a serious knock back in early 2017 when its plan to commercialise its drug, binimetinib, were derailed …

News

Array BioPharma demands $192m after AstraZeneca refuses to pay royalties

February 2, 2018
Medical Communications, Sales and Marketing Array Biopharma, AstraZeneca, lawsuit, selemetinib

Array BioPharma has launched a lawsuit against AstraZeneca over allegations the latter has refused to pay royalties it owes for …

News
shutterstock_273326141

BMS and Array BioPharma partner up to tackle colorectal cancer

May 30, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Array Biopharma, BMS, Bristol-Myers Squibb

Bristol-Myers Squibb and Array BioPharma have announced they are to join forces as part of a new clinical research partnership …

News
thumbs_down

Array BioPharma in disarray over withdrawal of NDA

March 20, 2017
Manufacturing and Production, Sales and Marketing Array Biopharma

Array BioPharma has announced that it has pulled its new drug application (NDA) for its drug, binimetinib, for the treatment …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026